White matter hyperintensities: age appropriate or risk indicator?

Alan R Stewart1

  • 1Community and Residential Services, Interior Health Authority, 220-1815 Kirschner Road, Kelowna, BC V1Y 4N7. alan.stewart@interiorhealth.ca

Insights

White matter hyperintensities (WMH) on MRI scans may indicate small vessel ischemic disease. These findings are linked to increased risks of stroke, cognitive decline, disability, and mortality in insurance applicants.

Area of Science:

  • Neurology
  • Radiology
  • Insurance Medicine

Background:

  • White matter hyperintensities (WMH) are common findings in MRI reports for insurance applicants.
  • The clinical significance and pathological correlates of WMH are often uncertain.
  • WMH are frequently associated with cerebrovascular disease and aging.

Purpose of the Study:

  • To review the relationship between WMH and health outcomes from an insurance medicine viewpoint.
  • To clarify the clinical significance of WMH in the context of morbidity, disability, and mortality.
  • To provide insights for insurance underwriting and risk assessment.

Main Methods:

  • Literature review of studies examining WMH and clinical outcomes.
  • Analysis of pathological correlates of WMH.
  • Examination of associations with stroke, cognitive impairment, dementia, disability, and mortality.

Main Results:

  • WMH patterns and extent vary in clinical significance.
  • Pathological correlates suggest WMH reflect small vessel ischemic burden.
  • Strong associations exist between WMH and adverse health outcomes including stroke and dementia.

Conclusions:

  • WMH are significant indicators of underlying cerebrovascular disease.
  • Findings have implications for assessing long-term health risks in insurance applicants.
  • Further research can refine risk stratification based on WMH characteristics.